The Massachusetts Psychosis Network for Early Treatment (MAPNET) and the New England Mental Health Technology Transfer Center (MHTTC) host a virtual monthly “Early Psychosis Prescriber Consultation Series” led by Dr. Matcheri Keshavan on prescribing practices for early psychosis, including a review of a selected monthly topic. Our May topic was “Long-Acting Injectable Antipsychotics (LAIs)."

​​Dr. Keshavan is Stanley Cobb Professor of Psychiatry at the Beth Israel Deaconess Medical Center, Harvard Medical School, as well as Academic Head of the department. He is the Editor-in-Chief of Schizophrenia Research (Elsevier) and serves on the editorial board for journals such as Early Intervention in Psychiatry and Asian Journal of Psychiatry. His main areas of research include the neurodevelopmental basis of schizophrenia, neuroimaging, and early intervention. He has an active clinical practice.